The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer
Abstract
Background: Non–small-cell lung cancer patients who continue to smoke after cancer diagnosis are more likely to experience disease recurrence, decreased treatment efficacy, and treatment complications. Despite this, many continue to smoke, with estimates ranging from 13% to ∼60%. Methods: Participants were 154 early-stage, non–small-cell lung cancer patients who had smoked within 3 months before surgery. Patients were followed for 12 months after surgery to assess smoking status and duration of continuous abstinence after surgery. Predictors included medical, smoking history, psychosocial, and demographic characteristics. Results: At some point after surgery, 42.9% of patients smoked; at 12 months after surgery, 36.9% were smoking. Sixty percent of patients who lapsed did so during the first 2 months after surgery. Smoking at follow-up was predicted by shorter quit duration before surgery, more intense Appetitive cravings (expectation of pleasure from smoking), lower income, and having a higher level of education. Time until the first smoking lapse was predicted by shorter quit duration before surgery, more intense Appetitive cravings to smoke, and lower income. Among those who lapsed, greater delay before the lapse was associated with abstinence at the 12-month follow-up assessment. Conclusions: Nearly half of non–small-cell lung cancer patients return to smoking after surgery if they have recent smoking histories. Most initial lapses happen within 2 months and occur in response to more recent smoking and more intense cravings. Findings suggest that interventions to prevent relapse should target those who wait until cancer surgery to quit smoking and should be started as soon as possible after treatment. (Cancer Epidemiol Biomarkers Prev 2006;15(12):2370–7)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These estimates are based on the self-reported quit rates at the 2-month follow-up observed in the Quit2Heal pilot trial, relapse by 12 months, and participant outcome data attrition.28,61–63”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [61]
In the citing paper
“With a sample of 422 (211 in each arm), wherein missing outcome data is imputed as smoking, if we observe a 13.6% 30-day PPA at the 12-month follow-up in the Quit2Heal arm and a 4.7% 30-day PPA at the 12-month follow-up in the QuitGuide arm, we will have at least 80% power to detect a clinically meaningful difference in smoking cessation between treatment arms.”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [61]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Treating tobacco use and dependence-Clinical practice guideline
Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616
Treating Tobacco Use and Dependence
(2008) · Pediatrics · doi:10.1542/peds.2008-1627 · Cited by 2,697
The CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument
MAYFIELD, D., MCLEOD, G., & HALL, P. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.10.1121 · Cited by 2,249
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
Fagerstrom, K. O., & Schneider, N. G. (1989) · Journal of Behavioral Medicine · doi:10.1007/bf00846549 · Cited by 1,598
On the Validity of the Beck Depression Inventory
Richter, P., Werner, J., Heerlein, A., Kraus, A., & Sauer, H. (1998) · Psychopathology · doi:10.1159/000066239 · Cited by 1,113
Research works printed but not linked: 2
- National Center for Health Statistics. Healthy People 2000 final review. Hyattsville (MD): Public Health Service; 2001.
- Walker MS. Smoking cessation—a practical approach. In: Govindan R, Arquette M, editors. Washington Manual of Oncology. Philadelphia (PA): Lippincott; 2002.
Cited by
Neurobiology of Nicotine Addiction: Implications for Smoking Cessation Treatment
Benowitz, N. L. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.015 · Cited by 385
Toll, B. A., Brandon, T. H., Gritz, E. R., Warren, G. W., & Herbst, R. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0666 · Cited by 205
“head and neck cancer survivors, experience short-term tobacco cessation rates as high as 70% immediately following cancer diagnosis (65), long-term relapse of this group can be as high as 50% and typically occurs within 1 to 6 months after cessation (65–67).”
BackgroundSelf-citationTobacco smoking after diagnosis of cancer: clinical aspects
Jassem, J. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.04.01 · Cited by 164
“Indeed, smoking rates reported by patients are apparently lower than those based on cotinine level verification (26,27).”
BackgroundTobacco use and cessation for cancer survivors: An overview for clinicians
Karam‐Hage, M., Cinciripini, P. M., & Gritz, E. R. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21231 · Cited by 139
Self-citationShiels, M. S., Gibson, T. M., Sampson, J. N., Albanes, D., Andreotti, G., Freeman, L. B., de González, A. B., Caporaso, N. E., Curtis, R. E., Elena, J. W., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8220 · Cited by 118
“Cigarette smoking remains common in cancer survivors, even among those diagnosedwithtobacco-relatedcancer.(3-6) Cancerpatientsmaynotrealize that they are at a higher risk of treatment complications, second primary cancers and death if they continue to smoke.”
Background
Metadata
- Authors
- Walker, M. S., Vidrine, D. J., Gritz, E. R., Larsen, R. J., Yan, Y., Govindan, R., & Fisher, E. B.
- Affiliations
- 1Departments of Medicine,
- The University of Texas MD Anderson Cancer Center (US)
- 2Psychology, and
- Washington University in St. Louis (US)
- University of North Carolina at Chapel Hill (US)
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2006-12-01
- Volume
- 15
- Issue
- 12
- Pages
- 2370-2377
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2164597448
- Cited by
- 147
- References
- 61
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 10 · 2018: 9 · 2017: 5 · 2016: 9 · 2015: 11 · 2014: 8 · 2013: 7 · 2012: 9
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alvin J. Siteman Cancer Center
- National Cancer Institute (P30 CA 91842, R01 CA85920, R01CA085920, P30CA091842)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- smoking relapse, non-small cell lung cancer, early-stage lung cancer, smoking cessation, predictors of relapse, socioeconomic factors, lung cancer surgery
- MeSH terms
- Attitude to Health, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Smoking, Time Factors, Tobacco Use Disorder, United States, Smoking Cessation, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. https://app.cochat.ai/papers/10.1158/1055-9965.epi-06-0509
- The paper
- Walker, M. S., Vidrine, D. J., Gritz, E. R., Larsen, R. J., Yan, Y., Govindan, R., & Fisher, E. B. (2006). Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-06-0509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.